Page 3 - Phase I News Today

Excitement surrounding the Hemlock Park Improvement Project in Big Rapids is mounting as...

Visitors to the Kruger National Park are set to benefit from a R320m infrastructure refurbishment programme that will run over the next three years.

Chhattisgarh governments ambitious project Ram Van Gaman tourism circuit is expected to complete its first phase by the end of this year or by mid of 2023.

The company plans to launch a Phase Ib/II study of its compound NVG-291 in collaboration with researchers at Northwestern University’s Shirley Ryan AbilityLab.

As 2021 comes to a close, a look back at the year show the continuing COVID-19 pandemic,...

The Public Utility Commission of Texas is making quick changes to electricity grid and...

No longer concealed behind stone gates and hedges, the museum’s grounds now have a...

Earlier this week, news broke that the borders between the U.S. and Mexico — as well as...

Grifols to launch trial for potential COVID-19 therapy The subcutaneously administered immunoglobulin, if successful, would provide rapid immunity against the virus behind the deadly global pandemic. Biopharmaceutical firm Grifols, which specializes in development of therapies harnessing plasma-derived proteins, has announced it is kicking off a clinical trial in Spain to test the viability of a potential COVID-19 treatment. Based on the company’s immunoglobulin Ga...

The immunotherapy-focused firm reports enrollment stands at 55% for its ongoing study exploring viability of Ampion as an inhalable COVID-19 treatment. Ampio Pharmaceuticals, a company specializing in immunology-based therapies for inflammatory conditions, has announced that its ongoing Phase I clinical trial in the US, exploring inhalation treatment of COVID-19 with Ampion (AP-014), is now 55% enrolled. The trial is looking at the impact of inhaled Ampion treatments...